$GLTO-patent reveals new galectin-3 and galectin-9 inhibitors
Potentially useful for the treatment of cancer, autoimmune disease, fibrosis, cardiovascular, eye, metabolic, cerebrovascular and inflammatory disorders, among others.
Up 22%/ Current Price $2.88